A study has suggested that an improved haptic design and adhesive biomaterial in a toric IOL work together to treat cataracts and corneal astigmatism, offering favorable rotational stability and ...

Please provide your email address to receive an email when new articles are posted on . FORT WORTH, Texas — A toric IOL for use in cataract patients with existing astigmatism has been granted U.S.

The unique optical design of the ACTIVEFOCUS (TM) toric IOL gives astigmatic cataract patients quality distance vision and an increased range of vision to potentially reduce dependence on glasses The ...

Background: To evaluate the rotational stability of the three types of AcrySof SA60TT toric intraocular lenses (Alcon, Switzerland) in cataract surgery after the first postoperative week. Methods: A ...

BASEL, Switzerland, January 26, 2017 - Alcon, the global leader in eye care and a division of Novartis, announces the launch of AcrySof ® IQ PanOptix ® Toric presbyopia- and astigmatism-correcting ...

To compare AcrySof toric intraocular lens (IOL) and non-toric IOL in patients who had combined 23-gauge microincisional vitrectomy surgery (MIVS) and phacoemulsification for vitreoretinal diseases and ...

Two human cadaver eyes were prepared in accordance with the Miyake–Apple technique, with closed-system modification. After phacoemulsification, an Acrysof Toric IOL was implanted in the capsular bag.

Here is the current list (as of Feb. 9, 2011) of posterior chamber (P-C) and anterior chamber (A-C) intraocular lenses recognized by CMS. – Crystalens, manufactured by Eyeonics (now Bausch & Lomb). – ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity ® Registry Study, which monitored ...

This is the first study to report the rotational stability of the AcrySof SA60TT toric IOL in a series of 44 cases 3 months after implantation in cataract surgery. In this series, the largest rotation ...

Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...